Cross-harbr (HLDGS) (HKG:32)

QUOTE AND NEWS
The Hindu Business Line  2 hrs ago  Comment 
Tractor sales broke their otherwise strong link with the monsoons in 2009. In a rainfall deficient year, tractor industry sales grew by 32 per cent for the 2009-10 fiscal. Mahindra and Mahi...
New York Times  12 hrs ago  Comment 
The ill-fated cruise ship was recently lifted to the surface, two and a half years after it ran aground in an accident that killed 32 people.
newratings.com  Jul 23  Comment 
WASHINGTON (dpa-AFX) - Virtualization software maker VMware Inc. (VMW) on Tuesday reported a 32 percent decline in profit for the second quarter from last year, as costs related to the company's acquisition of AirWatch more than...
Automotive World  Jul 22  Comment 
After 32 years of service, Paul Mascarenas retiring as chief technical officer and vice president, Research and Advanced Engineering, effective, Oct. 1 Dr. Ken Washington named vice president, Research and Advanced Engineering; former Lockheed...
The Hindu Business Line  Jul 20  Comment 
All-India rainfall is down to 32 per cent as of last evening as a low-pressure area takes shape anew in the northwest Bay of Bengal. The preparatory upper cyclonic circulation is already...
Reuters  Jul 19  Comment 
U.S. drugmaker AbbVie Inc bought Dublin-based Shire Plc on Friday in a 32 billion pound ($54.7 billion) deal that will allow it to slash its tax bill by relocating to Britain.
Reuters  Jul 18  Comment 
U.S. drugmaker AbbVie Inc bought Dublin-based Shire Plc on Friday in a 32 billion pound ($54.7 billion) deal that will allow it to slash its tax bill by relocating to Britain.
The Hindu Business Line  Jul 17  Comment 
With 32 seats, BJP is the single largest party in the 70-member Assembly
The Hindu Business Line  Jul 17  Comment 
The 32 years in the history of National Bank for Agriculture and Rural Development (Nabard) has demonstrated its eventful transformation from a fledgling aspirant to a leviathan development financ...
Benzinga  Jul 16  Comment 
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today unblinded results from its Phase 1/2 study for BL-7010,...





 


References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki